0001829959false9/30/202312/3100018299592023-09-30iso4217:USD00018299592022-12-3100018299592023-07-012023-09-3000018299592022-07-012022-09-3000018299592023-01-012023-09-3000018299592022-01-012022-09-30iso4217:USDxbrli:sharesxbrli:shares0001829959ifrs-full:OrdinarySharesMember2021-12-310001829959ifrs-full:AdditionalPaidinCapitalMember2021-12-310001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2021-12-310001829959ifrs-full:RetainedEarningsMember2021-12-3100018299592021-12-310001829959ifrs-full:OrdinarySharesMember2022-01-012022-09-300001829959ifrs-full:AdditionalPaidinCapitalMember2022-01-012022-09-300001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001829959ifrs-full:RetainedEarningsMember2022-01-012022-09-300001829959ifrs-full:OrdinarySharesMember2022-09-300001829959ifrs-full:AdditionalPaidinCapitalMember2022-09-300001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-09-300001829959ifrs-full:RetainedEarningsMember2022-09-3000018299592022-09-300001829959ifrs-full:OrdinarySharesMember2022-12-310001829959ifrs-full:AdditionalPaidinCapitalMember2022-12-310001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-12-310001829959ifrs-full:RetainedEarningsMember2022-12-310001829959ifrs-full:OrdinarySharesMember2023-01-012023-09-300001829959ifrs-full:AdditionalPaidinCapitalMember2023-01-012023-09-300001829959ifrs-full:RetainedEarningsMember2023-01-012023-09-300001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001829959ifrs-full:OrdinarySharesMember2023-09-300001829959ifrs-full:AdditionalPaidinCapitalMember2023-09-300001829959ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-09-300001829959ifrs-full:RetainedEarningsMember2023-09-300001829959docebo:DoceboSpAMember2023-01-012023-09-30xbrli:pure0001829959docebo:DoceboSpAMember2022-01-012022-12-310001829959docebo:DoceboNAIncMember2023-01-012023-09-300001829959docebo:DoceboNAIncMember2022-01-012022-12-310001829959docebo:DoceboEMEAFZLLCMember2023-01-012023-09-300001829959docebo:DoceboEMEAFZLLCMember2022-01-012022-12-310001829959docebo:DoceboUKMember2023-01-012023-09-300001829959docebo:DoceboUKMember2022-01-012022-12-310001829959docebo:DoceboFranceMember2023-01-012023-09-300001829959docebo:DoceboFranceMember2022-01-012022-12-310001829959docebo:DoceboGermanyMember2023-01-012023-09-300001829959docebo:DoceboGermanyMember2022-01-012022-12-310001829959docebo:DoceboAustraliaPtyLtdMember2023-01-012023-09-300001829959docebo:DoceboAustraliaPtyLtdMember2022-01-012022-12-310001829959docebo:DoceboIrelandLimitedMember2023-01-012023-09-300001829959docebo:DoceboIrelandLimitedMember2022-01-012022-12-310001829959docebo:CirclesCollectiveIncPeerBoardMember2023-01-012023-09-300001829959docebo:CirclesCollectiveIncPeerBoardMember2022-01-012022-12-310001829959docebo:EdugoAIHKLimitedMember2023-01-012023-09-300001829959docebo:EdugoAIHKLimitedMember2022-01-012022-12-310001829959docebo:CirclesCollectiveIncMember2023-04-030001829959ifrs-full:MajorBusinessCombinationMemberdocebo:CirclesCollectiveIncMember2023-04-03iso4217:CADxbrli:shares0001829959ifrs-full:MajorBusinessCombinationMemberdocebo:CirclesCollectiveIncMember2023-04-032023-04-030001829959docebo:CirclesCollectiveIncMember2023-04-032023-04-030001829959docebo:CirclesCollectiveIncMember2023-07-012023-09-300001829959docebo:CirclesCollectiveIncMember2023-01-012023-09-300001829959docebo:EdugoAIHKLimitedMember2023-06-090001829959ifrs-full:MajorBusinessCombinationMemberdocebo:EdugoAIHKLimitedMember2023-06-092023-06-090001829959docebo:EdugoAIHKLimitedMember2023-06-092023-06-090001829959docebo:EdugoAIHKLimitedMember2023-07-012023-09-300001829959docebo:EdugoAIHKLimitedMember2023-01-012023-09-300001829959ifrs-full:TradeReceivablesMember2023-09-300001829959ifrs-full:TradeReceivablesMember2022-12-310001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:GrossCarryingAmountMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001829959ifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:GrossCarryingAmountMemberifrs-full:OtherPropertyPlantAndEquipmentMember2023-01-012023-09-300001829959ifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:GrossCarryingAmountMemberifrs-full:OtherPropertyPlantAndEquipmentMember2023-09-300001829959ifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001829959ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherPropertyPlantAndEquipmentMember2023-01-012023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherPropertyPlantAndEquipmentMember2023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959ifrs-full:LandAndBuildingsMember2022-12-310001829959ifrs-full:OtherPropertyPlantAndEquipmentMember2022-12-310001829959ifrs-full:LandAndBuildingsMember2023-09-300001829959ifrs-full:OtherPropertyPlantAndEquipmentMember2023-09-300001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959docebo:FurnituresAndOfficeEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959ifrs-full:LandAndBuildingsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959docebo:FurnituresAndOfficeEquipmentMember2022-12-310001829959ifrs-full:LeaseholdImprovementsMember2022-12-310001829959ifrs-full:LandAndBuildingsMember2022-12-310001829959docebo:FurnituresAndOfficeEquipmentMember2023-09-300001829959ifrs-full:LeaseholdImprovementsMember2023-09-300001829959ifrs-full:LandAndBuildingsMember2023-09-300001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2022-12-310001829959ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-12-310001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-09-300001829959ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-01-012023-09-300001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-09-300001829959ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-09-300001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:TechnologybasedIntangibleAssetsMember2022-12-310001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-12-310001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:TechnologybasedIntangibleAssetsMember2023-01-012023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-01-012023-09-300001829959ifrs-full:CustomerrelatedIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:TechnologybasedIntangibleAssetsMember2023-09-300001829959ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-09-300001829959ifrs-full:CustomerrelatedIntangibleAssetsMember2022-12-310001829959ifrs-full:TechnologybasedIntangibleAssetsMember2022-12-310001829959ifrs-full:BrandNamesMember2022-12-310001829959ifrs-full:CustomerrelatedIntangibleAssetsMember2023-09-300001829959ifrs-full:TechnologybasedIntangibleAssetsMember2023-09-300001829959ifrs-full:BrandNamesMember2023-09-300001829959ifrs-full:GoodwillMember2022-12-310001829959ifrs-full:GoodwillMember2023-01-012023-09-300001829959ifrs-full:GoodwillMember2023-09-3000018299592023-04-2700018299592023-05-152023-05-1500018299592023-05-15docebo:component0001829959us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001829959us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001829959us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001829959us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001829959docebo:DeferredShareUnitsDSUMember2023-07-012023-09-300001829959docebo:DeferredShareUnitsDSUMember2022-07-012022-09-300001829959docebo:DeferredShareUnitsDSUMember2023-01-012023-09-300001829959docebo:DeferredShareUnitsDSUMember2022-01-012022-09-300001829959docebo:RestrictedStockUnitsMember2023-07-012023-09-300001829959docebo:RestrictedStockUnitsMember2022-07-012022-09-300001829959docebo:RestrictedStockUnitsMember2023-01-012023-09-300001829959docebo:RestrictedStockUnitsMember2022-01-012022-09-300001829959docebo:EmployeeSharePurchasePlanMember2023-07-012023-09-300001829959docebo:EmployeeSharePurchasePlanMember2022-07-012022-09-300001829959docebo:EmployeeSharePurchasePlanMember2023-01-012023-09-300001829959docebo:EmployeeSharePurchasePlanMember2022-01-012022-09-300001829959ifrs-full:CostOfSalesMember2023-07-012023-09-300001829959ifrs-full:CostOfSalesMember2022-07-012022-09-300001829959ifrs-full:CostOfSalesMember2023-01-012023-09-300001829959ifrs-full:CostOfSalesMember2022-01-012022-09-300001829959docebo:GeneralAndAdministrativeMember2023-07-012023-09-300001829959docebo:GeneralAndAdministrativeMember2022-07-012022-09-300001829959docebo:GeneralAndAdministrativeMember2023-01-012023-09-300001829959docebo:GeneralAndAdministrativeMember2022-01-012022-09-300001829959docebo:SalesAndMarketingExpenseMember2023-07-012023-09-300001829959docebo:SalesAndMarketingExpenseMember2022-07-012022-09-300001829959docebo:SalesAndMarketingExpenseMember2023-01-012023-09-300001829959docebo:SalesAndMarketingExpenseMember2022-01-012022-09-300001829959docebo:ResearchAndDevelopmentExpensesMember2023-07-012023-09-300001829959docebo:ResearchAndDevelopmentExpensesMember2022-07-012022-09-300001829959docebo:ResearchAndDevelopmentExpensesMember2023-01-012023-09-300001829959docebo:ResearchAndDevelopmentExpensesMember2022-01-012022-09-30utr:Y0001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeOneMember2023-09-300001829959docebo:ExercisePriceRangeOneMemberifrs-full:TopOfRangeMember2023-09-300001829959docebo:ExercisePriceRangeOneMember2023-09-300001829959docebo:ExercisePriceRangeOneMember2023-01-012023-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeTwoMember2023-09-300001829959docebo:ExercisePriceRangeTwoMemberifrs-full:TopOfRangeMember2023-09-300001829959docebo:ExercisePriceRangeTwoMember2023-09-300001829959docebo:ExercisePriceRangeTwoMember2023-01-012023-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeThreeMember2023-09-300001829959docebo:ExercisePriceRangeThreeMemberifrs-full:TopOfRangeMember2023-09-300001829959docebo:ExercisePriceRangeThreeMember2023-09-300001829959docebo:ExercisePriceRangeThreeMember2023-01-012023-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeFiveMember2023-09-300001829959docebo:ExercisePriceRangeFiveMemberifrs-full:TopOfRangeMember2023-09-300001829959docebo:ExercisePriceRangeFiveMember2023-09-300001829959docebo:ExercisePriceRangeFiveMember2023-01-012023-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeOneMember2022-09-300001829959docebo:ExercisePriceRangeOneMemberifrs-full:TopOfRangeMember2022-09-300001829959docebo:ExercisePriceRangeOneMember2022-09-300001829959docebo:ExercisePriceRangeOneMember2022-01-012022-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeTwoMember2022-09-300001829959docebo:ExercisePriceRangeTwoMemberifrs-full:TopOfRangeMember2022-09-300001829959docebo:ExercisePriceRangeTwoMember2022-09-300001829959docebo:ExercisePriceRangeTwoMember2022-01-012022-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeThreeMember2022-09-300001829959docebo:ExercisePriceRangeThreeMemberifrs-full:TopOfRangeMember2022-09-300001829959docebo:ExercisePriceRangeThreeMember2022-09-300001829959docebo:ExercisePriceRangeThreeMember2022-01-012022-09-300001829959ifrs-full:BottomOfRangeMemberdocebo:ExercisePriceRangeFourMember2022-09-300001829959docebo:ExercisePriceRangeFourMemberifrs-full:TopOfRangeMember2022-09-300001829959docebo:ExercisePriceRangeFourMember2022-09-300001829959docebo:ExercisePriceRangeFourMember2022-01-012022-09-300001829959docebo:DeferredShareUnitsDSUMember2022-12-310001829959docebo:DeferredShareUnitsDSUMemberifrs-full:BottomOfRangeMember2023-01-012023-09-300001829959docebo:DeferredShareUnitsDSUMemberifrs-full:TopOfRangeMember2023-01-012023-09-300001829959docebo:DeferredShareUnitsDSUMember2023-09-300001829959docebo:RestrictedStockUnitsMember2022-12-310001829959docebo:RestrictedStockUnitsMemberifrs-full:BottomOfRangeMember2023-01-012023-09-300001829959docebo:RestrictedStockUnitsMemberifrs-full:TopOfRangeMember2023-01-012023-09-300001829959docebo:RestrictedStockUnitsMember2023-09-30docebo:revenue_source0001829959docebo:SubscriptionRevenueMember2023-07-012023-09-300001829959docebo:SubscriptionRevenueMember2022-07-012022-09-300001829959docebo:SubscriptionRevenueMember2023-01-012023-09-300001829959docebo:SubscriptionRevenueMember2022-01-012022-09-300001829959docebo:ProfessionalServicesRevenueMember2023-07-012023-09-300001829959docebo:ProfessionalServicesRevenueMember2022-07-012022-09-300001829959docebo:ProfessionalServicesRevenueMember2023-01-012023-09-300001829959docebo:ProfessionalServicesRevenueMember2022-01-012022-09-300001829959srt:NorthAmericaMember2023-07-012023-09-300001829959srt:NorthAmericaMember2022-07-012022-09-300001829959srt:NorthAmericaMember2023-01-012023-09-300001829959srt:NorthAmericaMember2022-01-012022-09-300001829959docebo:RestOfWorldMember2023-07-012023-09-300001829959docebo:RestOfWorldMember2022-07-012022-09-300001829959docebo:RestOfWorldMember2023-01-012023-09-300001829959docebo:RestOfWorldMember2022-01-012022-09-30
                                                                                                                                                                    
DOCEBO INC.
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION
(expressed in thousands of United States dollars)


September 30,December 31,
2023
2022
$$
Assets
Current assets:
Cash and cash equivalents170,648 216,293 
Trade and other receivables (Note 5)
40,886 37,527 
Income taxes receivable36 435 
Prepaids and deposits7,529 6,378 
Net investment in finance lease 81 174 
Contract costs, net
5,484 2,778 
224,664 263,585 
Non-current assets:
Contract costs, net
9,395 7,931 
Net investment in finance lease61 241 
Deferred tax asset
104 118 
Right-of-use assets, net (Note 6)
1,563 2,038 
Property and equipment, net (Note 7)
2,120 2,624 
Intangible assets, net (Note 8)
6,410 1,150 
Goodwill (Note 9)
9,858 5,982 
254,175 283,669 
Liabilities
Current liabilities:
Trade and other payables30,576 26,025 
Automatic share repurchase plan liability (Note 11)
12,763  
Income taxes payable210 101 
Deferred revenue
64,612 55,779 
Contingent consideration1,153 1,083 
Lease obligations (Note 6)
1,513 1,374 
110,827 84,362 
Non-current liabilities:
Acquisition holdback payables1,034  
Contingent consideration 1,177 
Deferred revenue
782 528 
Lease obligations (Note 6)
881 1,692 
Employee benefit obligations
2,857 2,423 
Deferred tax liability
2,094 1,276 
118,475 91,458 
Shareholders’ equity
Share capital (Note 11)
261,643 268,194 
Contributed surplus11,637 8,458 
Accumulated other comprehensive loss
(8,979)(9,571)
Deficit
(128,601)(74,870)
Total equity135,700 192,211 
254,175 283,669 
The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

1

DOCEBO INC.
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
(expressed in thousands of United States dollars, except per share amounts)
Three months ended
September 30,
Nine months ended
September 30,
202320222023
2022
$$$$
Revenue (Note 14)
46,506 36,966 131,559 103,957 
Cost of revenue (Note 15 and 16)
8,779 7,140 25,243 20,671 
Gross profit37,727 29,826 106,316 83,286 
Operating expenses
General and administrative (Note 16)
8,317 7,824 25,218 22,796 
Sales and marketing (Note 16)
16,221 15,523 51,041 44,150 
Research and development (Note 16)
10,271 6,105 26,456 18,401 
Share-based compensation (Note 12)
1,845 1,000 4,438 3,624 
Foreign exchange (gain) loss
(3,092)(10,213)1,365 (11,676)
Depreciation and amortization (Note 6, 7 and 8)
1,056 564 2,587 1,731 
34,618 20,803 111,105 79,026 
Operating income (loss)
3,109 9,023 (4,789)4,260 
Finance income, net (Note 10)
(1,933)(1,325)(6,506)(1,677)
Other (income) expense, net
(2)(21)181 (64)
Income before income taxes
5,044 10,369 1,536 6,001 
Income tax expense
997 95 1,918 583 
Net income (loss) for the periods
4,047 10,274 (382)5,418 
Other comprehensive loss (income)
Item that may be reclassified subsequently to income:
Exchange loss (gain) on translation of foreign operations
3,776 10,690 (592)12,633 
Comprehensive income (loss)
271 (416)210 (7,215)
Income per share - basic0.12 0.31 (0.01)0.16
Income per share - diluted0.12 0.30 (0.01)0.16
Weighted average number of common shares outstanding - basic (Note 13)
32,474,975 33,044,250 32,907,374 33,024,887 
Weighted average number of common shares outstanding - diluted (Note 13)
33,513,101 34,069,688 32,907,374 34,032,666 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

2

DOCEBO INC.
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(expressed in thousands of United States dollars, except number of shares)

Share capitalContributed surplus
Accumulated other comprehensive income (loss)
Deficit
Total
#$$$$$
Balance, December 31, 2021
32,857,422 266,119 4,312 2,113 (81,888)190,656 
Exercise of stock options (Note 11 and 12)
9,179 151 (63)— — 88 
Share-based compensation (Note 12)
— — 3,624 — — 3,624 
Release of RSUs (Note 11 and 12)
2,800 194 (194)— —  
Issuance of common shares related to business combination15,364 700 — — — 700 
Share issuance under employee share purchase plan (Note 11 and 12)
20,814 762 (126)— — 636 
Comprehensive loss— — — (12,633)5,418 (7,215)
Balance, September 30, 2022
32,905,579 267,926 7,553 (10,520)(76,470)188,489 
Balance, December 31, 2022
32,913,955 268,194 8,458 (9,571)(74,870)192,211 
Exercise of stock options (Note 11 and 12)
194,188 1,018 (318)— — 700 
Share-based compensation (Note 12)
— — 4,438 — — 4,438 
Share issuance under employee share purchase plan (Note 11 and 12)
16,685 614 (90)— — 524 
Release of restricted share units (Note 11 and 12)
19,744 851 (851)— —  
Shares issued related to contingent consideration50,550 1,625 — — — 1,625 
Shares repurchased for cancellation under normal course issuer bid (Note 11)
(1,333,361)(10,659)— — (40,586)(51,245)
Share repurchase commitment under the automatic share purchase plan (Note 11)
— — — — (12,763)(12,763)
Comprehensive income (loss)— — — 592 (382)210 
Balance, September 30, 2023
31,861,761 261,643 11,637 (8,979)(128,601)135,700 


The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

3

DOCEBO INC.
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS
(expressed in thousands of United States dollars)

Nine months ended
September 30,
2023
2022
$$
Cash flows from operating activities
Net (loss) income
(382)5,418 
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization2,587 1,731 
Share-based compensation4,438 3,624 
Loss on disposal of asset
197 11 
Unrealized foreign exchange loss (gain)
723 (12,215)
Income tax expense
1,918 583 
Finance income, net
(6,506)(1,677)
Changes in non-cash working capital items:
Trade and other receivables(2,321)(3,483)
Prepaids and deposits(1,178)190 
Contract costs(4,188)(3,982)
Trade and other payables5,201 1,578 
Employee benefit obligations461 467 
Deferred revenue9,171 8,542 
Income taxes (paid) received(633)(692)
Cash from operating activities
9,488 95 
Cash flows used in investing activities
Purchase of property and equipment(386)(860)
Payments of contingent consideration from acquisitions(216)(93)
Acquisition of business, net of cash acquired(8,671)(1,071)
Cash used in investing activities
(9,273)(2,024)
Cash flows (used in) from financing activities
Payments received on net investment in finance lease84 116 
Repayment of lease obligations(1,319)(1,044)
Interest received5,636 827 
Proceeds from exercise of stock options700 88 
Proceeds from share issuance under employee share purchase plan524 636 
Shares repurchased for cancellation under normal course issuer bid(51,245) 
Cash (used in) from financing activities
(45,620)623 
Net change in cash and cash equivalents during the period
(45,405)(1,306)
Effect of foreign exchange on cash and cash equivalents(240)(1,284)
Cash and cash equivalents, beginning of the period
216,293 215,323 
Cash and cash equivalents, end of the period
170,648 212,733 

The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.

4

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
1Nature of business

Docebo Inc. (the “Company” or “Docebo”) is a provider of cloud-based learning management systems. The Company was incorporated on April 21, 2016 under the laws of the Province of Ontario. The Company’s head office is located at Suite 701, 366 Adelaide Street West, Toronto, Canada, M5V 1R9.

The Company’s shares are listed on both the Toronto Stock Exchange (“TSX”), as of October 8, 2019, and the Nasdaq Global Select Market (“Nasdaq”), as of December 3, 2020, under the stock symbol “DCBO”.

The Company has the following subsidiaries:

Entity nameCountry
Ownership percentage
September 30,
2023
Ownership percentage
December 31, 2022
%%
Docebo S.p.AItaly100100
Docebo NA, Inc.United States100100
Docebo EMEA FZ-LLCDubai100100
Docebo UK LimitedEngland100100
Docebo France Société par Actions Simplifiée (“Docebo France”)France100100
Docebo DACH GmbH (“Docebo Germany”)Germany100100
Docebo Australia Pty Ltd. ("Docebo Australia")Australia100100
Docebo Ireland LimitedIreland100100
Circles Collective Inc. ("PeerBoard")United States100
Edugo AI HK LimitedHong Kong100

2Basis of preparation

Statement of compliance

The unaudited condensed consolidated interim financial statements (“financial statements”) have been prepared by management using the same accounting policies and methods as those used in the Company’s consolidated financial statements for the year ended December 31, 2022. These unaudited condensed consolidated interim financial statements have been prepared in accordance with IAS 34 – Interim Financial Reporting. Accordingly, certain disclosures normally included in annual financial statements prepared in accordance with IFRS Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) have been omitted or condensed. These unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements for the year ended December 31, 2022.

These financial statements were approved and authorized for issuance by the Board of Directors of the Company on November 8, 2023.

Use of estimates, assumptions and judgments

The preparation of these financial statements in conformity with IFRS requires management to make estimates, assumptions and judgments that affect the application of accounting policies and the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual results may differ from those estimates.


5

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

In preparing these financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of uncertainty are the same as those applied and described in the Company’s annual audited consolidated financial statements for the year ended December 31, 2022.

3Summary of significant accounting policies

The significant accounting policies applied in these financial statements are the same as those applied and described in the Company’s annual audited consolidated financial statements as at and for the year ended December 31, 2022.

4Business combinations

Circles Collective Inc.

On April 3, 2023, the Company acquired all of the issued and outstanding shares of Circles Collective Inc. (o/a PeerBoard), a plug and play community-as-a-service platform based in the United States. The acquisition of PeerBoard will expand Docebo’s external training offering and enhance the Company’s social learning capabilities.

Total purchase consideration of $2,991, consisting of: (i) cash paid on closing of $2,526; and (ii) a cash holdback amount of $466 (maximum undiscounted amount of $500) payable on the second year anniversary of the acquisition. The issuance of an additional 26,185 common shares, at a fair value of $40.74 (C$51.68) per share, is payable through April 2026 to an employee of the acquiree contingent on continued employment and is accounted for as compensation for post-acquisition services.

In addition, potential future consideration of up to $4,000 in cash over the three years following the closing date is owing to an employee of the acquiree based on the achievement of both performance milestones and continued employment. Given the continued employment requirement, these earn-out payouts will be accounted for as compensation for post-acquisition services and are not considered purchase consideration in the business combination.

Transaction costs relating to due diligence fees, legal costs, accounting fees, advisory fees and other professional fees for the three and nine months ended September 30, 2023 amounting to $23 and $522, respectively, were incurred in relation to the acquisition. These amounts have been included in general and administrative expenses in the Company's condensed consolidated interim statements of income and comprehensive income (loss).

The acquisition has been accounted for as a business combination in accordance with IFRS 3, Business Combinations, using the acquisition method whereby the net assets acquired and the liabilities assumed are recorded at fair value.

The following table summarizes the preliminary allocations of the consideration paid and the amounts of fair value of the assets acquired and liabilities assumed at the acquisition date:
Fair value recognized on acquisition
$
Assets
Current assets:

6

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Cash and cash equivalents2 
2 
Non-current assets:
Technology1,830 
Goodwill1,210 
Total assets3,042 
Liabilities
Current liabilities:
Trade and other payables2 
Deferred revenue1 
3 
Non-current liabilities:
Deferred tax liability48 
Total liabilities51 
Fair value of net assets acquired2,991 
Paid in cash2,526 
Holdback payable466 
Working capital adjustment(1)
Total purchase consideration2,991 

The goodwill related to the acquisition of PeerBoard reflects the benefits attributable to future market development and the fair value of an assembled workforce. These benefits were not recognized separately from goodwill because they did not meet the recognition criteria for identifiable intangible assets. This goodwill is not deductible for income tax purposes.

The technology acquired is amortized on a straight-line basis over the estimated useful life of 5 years.

The allocation of the purchase price to assets acquired and liabilities assumed was based upon a preliminary valuation for all items and may be subject to adjustment during the 12-month measurement period following the acquisition date.

Edugo AI HK Limited

On June 9, 2023, the Company acquired all of the issued and outstanding shares of Edugo AI HK Limited (“Edugo.AI”), a Generative AI-based Learning Technology that uses advanced Large Language Models and algorithms to optimize learning paths and adapt to individual learner needs.

Total purchase consideration of $6,731 consisted of: (i) cash paid on closing of $6,151; (ii) a cash holdback amount of $552 (maximum undiscounted amount of $603) payable on the second year anniversary of the acquisition; and (iii) a pre-closing expense advance and post-close working capital adjustment of $28.

In addition, up to $8,028 of additional cash consideration may be payable over the three years following the closing of the transaction, representing the earn-out portion of the consideration paid by the Company or subsidiary thereof in connection with the transaction, based on the achievement of certain performance milestones and employment obligations. Given the continued employment requirement, these earn-out payouts will be accounted for as compensation for post-acquisition services and are not considered purchase consideration in the business combination.


7

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Transaction costs relating to due diligence fees, legal costs, accounting fees, advisory fees and other professional fees for the three and nine months ended September 30, 2023 amounting to $218 and $551, respectively, were incurred in relation to the acquisition. These amounts have been included in general and administrative expenses in the Company's condensed consolidated interim statements of income and comprehensive income (loss).

The acquisition has been accounted for as a business combination in accordance with IFRS 3, Business Combinations, using the acquisition method whereby the net assets acquired and the liabilities assumed are recorded at fair value.

The following table summarizes the preliminary allocations of the consideration paid and the amounts of fair value of the assets acquired and liabilities assumed at the acquisition date:
Fair value recognized on acquisition
$
Assets
Current assets:
Cash and cash equivalents4 
4 
Non-current assets:
Technology4,126 
Goodwill2,772 
Total assets6,902 
Liabilities
Current liabilities:
Trade and other payables171 
Total liabilities171 
Fair value of net assets acquired6,731 
Paid in cash6,151 
Holdback payable552 
Pre-funded expenses38 
Working capital adjustment(10)
Total purchase consideration6,731 

The goodwill related to the acquisition of Edugo.AI reflects the benefits attributable to future market development and the fair value of an assembled workforce. These benefits were not recognized separately from goodwill because they did not meet the recognition criteria for identifiable intangible assets. This goodwill is not deductible for income tax purposes.

The technology acquired is amortized on a straight-line basis over the estimated useful life of 5 years.

The allocation of the purchase price to assets acquired and liabilities assumed was based upon a preliminary valuation for all items and may be subject to adjustment during the 12-month measurement period following the acquisition date.

8

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
5Trade and other receivables

The Company’s trade and other receivables as at September 30, 2023 and December 31, 2022 include the following:
2023
2022
$$
Trade receivables35,023 29,128 
Accrued revenues2,700 3,288 
Tax credits receivable1,984 3,054 
Interest receivable1,087 1,662 
Other receivables92 395 
40,886 37,527 

Included in trade receivables is a loss allowance of $986 as at September 30, 2023 and $719 as at December 31, 2022.

6Leases

The Company’s right-of-use assets by class of assets are as follows:
PremisesOthersTotal
$$$
Costs
Balance – December 31, 2022
4,7173825,099
Additions540540
Effects of foreign exchange(18)(5)(23)
Balance – September 30, 2023
5,2393775,616
Accumulated amortization
Balance – December 31, 2022
2,7962653,061
Amortization975451,020
Effects of foreign exchange(31)3(28)
Balance – September 30, 2023
3,7403134,053
Carrying value
Net balance – December 31, 2022
1,9211172,038
Net balance – September 30, 2023
1,499641,563


9

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
The Company’s lease obligations are as follows:
2023
$
Balance – January 13,066 
Additions540 
Interest accretion163 
Lease repayments(1,319)
Effects of foreign exchange(56)
Balance – September 302,394 
Current1,513 
Non-current881 
2,394 

Expenses incurred for the three and nine months ended September 30, 2023 relating to short-term leases and leases of low-value assets were $22 and $90, respectively (2022 - $47 and $163).

7Property and equipment
Furniture and office equipmentLeasehold improvementsLand and BuildingTotal
$$$$
Cost
Balance – December 31, 2022
2,983 1,864 332 5,179 
Additions334 52  386 
Effects of foreign exchange(28)(11)(4)(43)
Balance – September 30, 2023
3,289 1,905 328 5,522 
Accumulated depreciation
Balance – December 31, 2022
1,493 979 83 2,555 
Depreciation624 243 8 875 
Effects of foreign exchange(18)(7)(3)(28)
Balance – September 30, 2023
2,099 1,215 88 3,402 
Carrying value
Balance – December 31, 2022
1,490 885 249 2,624 
Balance – September 30, 2023
1,190 690 240 2,120 

8Intangible assets
Acquired
Customer relationshipsTechnologyTrademarksTotal
$$$$
Cost
Balance – December 31, 2022
1,335 502 43 1,880 
Acquisitions through business combinations 5,956  5,956 
Effects of foreign exchange(15)(5) (20)
Balance – September 30, 2023
1,320 6,453 43 7,816 

10

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Acquired
Customer relationshipsTechnologyTrademarksTotal
Balance – December 31, 2022
483 218 29 730 
Amortization168 512 12 692 
Effects of foreign exchange(8)(7)(1)(16)
Balance – September 30, 2023
643 723 40 1,406 
Carrying value
Balance – December 31, 2022
852 284 14 1,150 
Balance – September 30, 2023
677 5,730 3 6,410 

9Goodwill

$
Balance – December 31, 2022
5,982 
Additions3,982 
Effects of foreign exchange(106)
Balance – September 30, 2023
9,858 

10Finance income, net

Finance income for the three and nine months ended September 30, 2023 and 2022 is comprised of:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Interest on acquisition related consideration28 28 64 83 
Interest on lease obligations51 63 163 207 
Interest income(2,012)(1,416)(6,733)(1,969)
Bank fees and other   2 
(1,933)(1,325)(6,506)(1,677)

11Share capital
Authorized:
Unlimited common shares with no par value
Issued and outstanding:
Number of shares
Amount
#$

11

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Balance – December 31, 2022
32,913,955 268,194 
Exercise of stock options194,188 1,018 
Issuance of common shares under employee share purchase plan16,685 614 
Release of restricted share units19,744 851 
Issuance of common shares related to contingent consideration50,550 1,625 
Purchase of common shares held for cancellation under normal course issuer bid(1,333,361)(10,659)
Balance – September 30, 2023
31,861,761 261,643 

On April 27, 2023, the Company issued a total of 50,550 common shares from treasury as part of the contingent consideration earn-out payments due to the sellers of forMetris Société par Actions Simplifiée for meeting certain revenue conditions in the second year following the date of acquisition. The shares were issued based on the fair value thereof, which was determined to be $32.09 (C$44.74). The equity settlement resulted in a reduction to the contingent consideration balance as at June 30, 2022.

On May 15, 2023, the Company announced the commencement of a normal course issuer bid (“NCIB”) to repurchase and cancel up to 1,650,672 of its common shares, representing approximately 5% of the public float, over the 12-month period commencing May 18, 2023, and ending no later than May 17, 2024. All repurchases are made through the facilities of the Toronto Stock Exchange and are done at market prices. The amounts paid above the average book value of the common shares are charged to retained earnings. During the nine months ended September 30, 2023, the Company repurchased a total of 1,333,361 common shares for cancellation at an average price of $38.43 (C$50.27) per common share for total cash consideration of $51,245. As at September 30, 2023, $831 of consideration related to common share repurchases was recorded in trade and other payables.

In connection with the NCIB, the Company entered into an automatic share purchase plan ("ASPP") with a designated broker for the purpose of allowing the Company to purchase its common shares under the NCIB during self-imposed trading blackout periods. Under the ASPP, the broker is authorized to repurchase common shares during blackout periods, without consultation with the Company, on predefined terms, including share price, time period and subject to other limitations imposed by the Company and subject to rules and policies of the TSX and applicable securities laws, such as a daily purchase restriction.

A liability representing the maximum amount that the Company could be required to pay the designated broker under the ASPP was $12,763 as at September 30, 2023. The amount was charged to retained earnings.

12Share-based compensation

The Company has five components of its share-based compensation plan: stock options, deferred share units (“DSUs”), restricted share units (“RSUs”), performance share units (“PSUs”) and employee share purchase plan (“ESPP”). Share-based compensation expense for the three and nine months ended September 30, 2023 was $1,845 and $4,438, respectively (2022 - $1,000 and $3,624). The expense associated with each component is as follows:

Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Stock options743 607 1,769 1,655 
DSUs269 233 722 632 
RSUs806 124 1,862 1,225 
ESPP27 36 85 112 
1,845 1,000 4,438 3,624 

There were no PSUs issued and outstanding for the three and nine months ended September 30, 2023 and 2022.

12

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
The following table presents share-based compensation expense by function for the three and nine months ended September 30:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Cost of revenue90 21 206 215 
General and administrative1,005 480 2,530 2,142 
Sales and marketing552 472 1,056 1,225 
Research and development198 27 646 42 
1,845 1,000 4,438 3,624 

The changes in the number of stock options during the nine months ended September 30, 2023 and 2022 were as follows:
2023
2022
Number of optionsWeighted average exercise priceNumber of optionsWeighted average exercise price
#C$#C$
Options outstanding – January 11,349,001 13.60 1,283,088 12.00 
Options granted236,753 52.15 168,588 44.91 
Options forfeited(98,570)42.67 (63,415)46.41 
Options exercised(194,188)4.88 (9,179)14.52 
Options outstanding – September 30
1,292,996 19.75 1,379,082 14.42 
Options exercisable – September 30
850,250 7.59 887,779 4.06 

The weighted average fair value of share options granted during the nine months ended September 30, 2023 and 2022 was estimated at the date of grant using the Black-Scholes option pricing model using the following inputs:

2023
2022
C$C$
Weighted average stock price valuation$52.15 $44.91 
Weighted average exercise price$52.15 $44.91 
Risk-free interest rate3.11 %2.58 %
Expected life in years4.56.25
Expected dividend yield % %
Volatility64 %63 %
Weighted average fair value of options issued$28.15 $26.94 

The following table is a summary of the Company’s stock options outstanding as at September 30, 2023:

13

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Options outstandingOptions exercisable
Exercise price rangeNumber outstandingWeighted average remaining contractual life (years)Exercise price rangeNumber exercisable
C$##C$#
0.0001 - 1.09
639,920 2.13
0.0001 - 1.09
639,920 
8.86 - 11.06
43,811 7.16
8.86 - 11.06
27,126 
15.79 - 16.00
196,930 6.03
15.79 - 16.00
107,481 
26.43 - 95.12
412,335 6.25
26.43 - 95.12
75,723 
1,292,996 4.21850,250 

The following table is a summary of the Company’s stock options outstanding as at September 30, 2022:
Options outstandingOptions exercisable
Exercise price rangeNumber outstandingWeighted average remaining contractual life (years)Exercise price rangeNumber exercisable
C$##C$#
0.0001 - 1.09
784,368 4.71
0.0001 - 1.09
748,368 
8.86 - 11.06
51,811 8.20
8.86 - 11.06
21,084 
15.79 - 16.00
268,499 7.03
15.79 - 16.00
95,969 
26.43 - 95.12
274,404 9.26
26.43 - 95.12
22,358 
1,379,082 6.19887,779 

DSUs

The following table presents information concerning the number of DSUs granted by the Company:
#
DSUs – December 31, 2022
87,222 
Granted (at C$43.93 - $53.15 per unit)
26,813 
DSUs - September 30, 2023
114,035 

RSUs

The following table presents information concerning the number of RSUs granted by the Company:
#
RSUs – December 31, 2022
103,626 
Granted (at C$43.55 - $52.38 per unit)
127,753 
Released (at C$40.30 - $86.38 per unit)
(19,744)
Forfeited (at C$42.24 - $86.38 per unit)
(40,310)
RSUs - September 30, 2023
171,325 

13Net income (loss) per share


14

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
Basic and diluted net income per share for the three and nine months ended September 30 are calculated as follows:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
Net income (loss) attributable to common shareholders4,047 10,274 $(382)$5,418 
Basic weighted average number of common shares outstanding32,474,975 33,044,250 32,907,374 33,024,887 
Stock options730,652 815,863  850,888 
DSUs113,272 84,254  68,749 
RSUs194,202 125,321  88,142 
Diluted weighted average number of common shares outstanding33,513,101 34,069,688 32,907,374 34,032,666 
Basic net income (loss) per common share$0.12 $0.31 $(0.01)$0.16 
Diluted net income (loss) per common share$0.12 $0.30 $(0.01)$0.16 

For the three and nine months ended September 30, 2023, there were 87,867 and all share options and units, respectively, (three and nine months ended September 30, 2022 – nil and 15,991 shares, respectively) that were not taken into account in the calculation of diluted earnings per share because their effect was anti-dilutive.

14Revenue and related balances

Disaggregated revenue

The Company derives its revenues from two main sources, subscription to its SaaS application, and professional services revenue, which includes services such as initial implementation, project management, and training.

The following table presents a disaggregation of revenue for the three and nine months ended September 30:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Subscription revenue43,588 34,279 123,278 95,323 
Professional services2,918 2,687 8,281 8,634 
46,506 36,966 131,559 103,957 

15Cost of revenue

The following table represents cost of revenue for the three and nine months ended September 30:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Employee salaries and benefits4,576 3,873 13,875 12,149 
Web hosting fees1,299 1,329 3,701 3,589 
Third party service fees2,605 1,763 6,878 4,361 
Other299 175 789 572 
8,779 7,140 25,243 20,671 


15

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
16Employee compensation

The total employee compensation comprising salaries and benefits, and excluding share-based compensation, for the three and nine months ended September 30, 2023 was $27,104 and $81,927, respectively (2022 - $22,954 and $67,543).
Employee compensation costs were included in the following expenses for the three and nine months ended September 30:    
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Cost of revenue4,576 3,873 13,875 12,149 
General and administrative4,089 3,582 11,909 10,328 
Sales and marketing11,380 10,900 35,957 31,013 
Research and development7,059 4,599 20,186 14,053 
27,104 22,954 81,927 67,543 

17Related party transactions

Key management personnel are those persons having the authority and responsibility for planning, directing and controlling activities of the Company, directly or indirectly. Key management personnel includes the Company’s Directors and Officers.

Compensation awarded to key management personnel for the three and nine months ended September 30, 2023 and 2022 is as follows:
Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
Salaries and benefits1,308 1,082 3,589 2,590 
Share-based compensation1,108 425 3,245 2,106 
2,416 1,507 6,834 4,696 

18Financial instruments and risk management

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from deposits with banks and outstanding receivables. The Company trades only with recognized, creditworthy third parties. Due to the Company’s diversified customer base, there is no particular concentration of credit risk related to the Company’s trade and other receivables. Trade and other receivables are monitored on an ongoing basis to ensure timely collection of amounts.

The carrying values of cash and cash equivalents, trade and other receivables, trade and other payables, and ASPP liability approximate fair values due to the short-term nature of these items or being carried at fair value. The risk of material change in fair value is not considered to be significant. The Company does not use derivative financial instruments to manage this risk.

Contingent consideration is classified as a Level 3 financial instrument. The fair value of the contingent consideration was calculated using discounted cash flows. During the three and nine months ended September 30, 2023, there were no transfers of amounts between levels in the fair value hierarchy.


16

DOCEBO INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
September 30, 2023
(expressed in thousands of US dollars, except share amounts)
19Segment information

The Company reports segment information based on internal reports used by the chief operating decision maker (“CODM”) to make operating and resource allocation decisions and to assess performance. The CODM is the Chief Executive Officer. The CODM makes decisions and assesses performance of the Company on a consolidated basis such that the Company is a single reportable operating segment.

The following tables present details on revenues derived in the following geographical locations for the three and nine months ended September 30, 2023 and 2022.

Three months ended September 30,
Nine months ended September 30,
2023
2022
2023
2022
$$$$
North America35,462 28,439 99,834 78,731 
Rest of World
11,044 8,527 31,725 25,226 
46,506 36,966 131,559 103,957 


17